Relevant bibliographies by topics / Cell Immunotherapy / Books

Books on the topic 'Cell Immunotherapy'

To see the other types of publications on this topic, follow the link: Cell Immunotherapy.
Author: Grafiati
Published: 9 March 2023
Last updated: 11 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Cell Immunotherapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Katz, Samuel G., and Peter M. Rabinovich, eds. Cell Reprogramming for Immunotherapy. New York, NY: Springer US, 2020. http://dx.doi.org/10.1007/978-1-0716-0203-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Debruyne, Frans M. J., Ronald M. Bukowski, J. Edson Pontes, and Pieter H. M. de Mulder, eds. Immunotherapy of Renal Cell Carcinoma. Berlin, Heidelberg: Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-75853-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

1955-, Klein Eric A., Bukowski Ronald M, and Finke James H. 1944-, eds. Renal cell carcinoma: Immunotherapy and cellular biology. New York: Marcel Dekker, Inc., 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

1950-, Morstyn George, and Sheridan William 1954-, eds. Cell therapy: Stem cell transplantation, gene therapy, and cellular immunotherapy. Cambridge: Cambridge University Press, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Debruyne, F. M. J., 1941- and Ackermann R. 1941-, eds. Immunotherapy of renal cell carcinoma: Clinical and experimental developments. Berlin: Springer-Verlag, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Burkhard, Ludewig, and Hoffmann Matthias W, eds. Adoptive immunotherapy: Methods and protocols. Totowa, N.J: Humana Press, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

N, Winter Jane, ed. Blood stem cell transplantation. Boston: Kluwer Academic Publishers, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

M, Bukowski Ronald, Finke James H. 1944-, and Klein Eric A. 1955-, eds. Biology of renal cell carcinoma. New York: Springer-Verlag, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Donnadieu, Emmanuel, ed. Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-42223-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

1956-, Zhang Jingwu, and Cohen Irun R, eds. T-cell vaccination. New York: Nova Biomedical Books, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Cell wars: The immune system's newest weapons against cancer. New York: Fromm International Pub. Corp., 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Cell wars: The immune system's newest weapons against cancer. New York: Farrar, Straus, Giroux, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

J, Raus, ed. T cell vaccination and autoimmune disease. New York: Springer-Verlag, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Dijk, Jeroen van. Renal cell carcinoma: Diagnostic and therapeutic applications of monoclonal antibodies. [The Netherlands: s.n.], 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Wiwanitkit, Viroj. Cell, gene, and molecular therapy: New concepts. Hauppauge, NY: Nova Science Publishers, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Kang, Chʻang-yul. Pairŏsŭ pektʻŏ ro hyŏngjil toiptoen hangwŏn chesi sepʻo ŭi myŏnyŏk chʻiryoje yuhyosŏng pʻyŏngka mit sihŏmpŏp yŏnʼgu =: Development and estimation of immunotherapeutic cell-based vaccine approaches using antigen presenting cells transduced with viral vector. [Seoul]: Sikpʻum Ŭiyakpʻum Anjŏnchʻŏng, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

K, Singhal S., Delovitch T. L, and Canadian Society for Immunology, eds. Mediators of immune regulation and immunotherapy: Proceedings of the international symposium, Mediators of immune regulation and immunotherapy, held June 13-15, 1985, at the University of Western Ontario, London, Ontario, Canada. New York: Elsevier, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

1960-, Bashey Asad, and Ball Edward D. 1950-, eds. Non-myeloablative allogeneic transplantation. Boston: Kluwer Academic Publishers, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

E, Berdel Wolfgang, ed. Transplantation in hematology and oncology II. Berlin: Springer, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

H, Wekerle, Graf H, and Turner J. D, eds. Cellular therapy. Berlin: Springer, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

M, Brush Mary, and Burt Richard K. 1956-, eds. Advances in allogeneic hematopoietic stem cell transplantation. Boston, Mass: Kluwer Academic, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

1948-, Jeannin Jean-François, ed. Lipid A in cancer therapy. New York: Springer Science+Business Media, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

1948-, Jeannin Jean-François, ed. Lipid A in cancer therapy. New York: Springer Science+Business Media, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

service), SpringerLink (Online, ed. Cell Therapy: CGMP Facilities and Manufacturing. Boston, MA: Springer-Verlag US, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

J, Fairbairn Leslie, and Testa Nydia G. 1938-, eds. Hematopoiesis and gene therapy. New York: Kluwer Academic/Plenum Publishers, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

1955-, Haas R., Kronenwett R. 1966-, and Sczakiel G. 1956-, eds. Advances in hematopoietic stem cell transplantation and molecular therapy. Berlin: Springer, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Sheldon, Katherine. Dendritic cells: Targets for immunotherapy. Westborough, MA: D & MD Publications, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

L, Kripke Margaret, Frost Philip 1940-, and M.D. Anderson Hospital and Tumor Institute., eds. Immunology and cancer. Austin: Published for the University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, Tex. by the University of Texas Press, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Vibeke, Strand, Scott David L. 1951-, and Simon Lee S, eds. Novel therapeutic agents for the treatment of autoimmune diseases. New York: M. Dekker, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Borrego, Francisco, Susana Larrucea, Rafael Solana, and Raquel Tarazona, eds. NK Cell-Based Cancer Immunotherapy. Frontiers Media SA, 2016. http://dx.doi.org/10.3389/978-2-88919-934-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Farghaly, Samir A. Adoptive Cell Immunotherapy for Epithelial Ovarian Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0005.

Full text
Abstract:
The standard management for epithelial ovarian cancer (EOC) is a combination of aggressive debulking surgery with residual tumor of less than 1 cm and platinum-based chemotherapy. However, a high percentage of patients experience disease recurrence. Extensive efforts to find new therapeutic options have been made, albeit cancer cells develop drug resistance and malignant progression occurs. Novel therapeutic strategies are needed to enhance progression-free survival and overall survival of patients with advanced EOC. Several preclinical and clinical studies investigated feasibility and efficacy of adoptive cell therapy (ACT) in EOC. The aim of this chapter is to present an overview of ACT in EOC, focusing on Human Leukocyte Antigen (HLA)-restricted tumor infiltrating lymphocytes and MHC-independent immune effectors such as natural killer and cytokine-induced killer. The available data suggest that ACT may provide the best outcome in patients with low tumor burden, minimal residual disease, or maintenance therapy. Further preclinical studies and clinical trials are needed.
APA, Harvard, Vancouver, ISO, and other styles
32

Santich, Brian H., Nai-Kong Cheung, and Christian Klein, eds. Bispecific Antibodies for T-Cell Based Immunotherapy. Frontiers Media SA, 2021. http://dx.doi.org/10.3389/978-2-88966-415-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Rabinovich, Peter M., and Samuel G. Katz. Cell Reprogramming for Immunotherapy: Methods and Protocols. Springer, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Rabinovich, Peter M., and Samuel G. Katz. Cell Reprogramming for Immunotherapy: Methods and Protocols. Springer, 2019.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Farghaly, Samir A., ed. Ovarian Cancer Immunotherapy. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.001.0001.

Full text
Abstract:
Ovarian Cancer Immunotherapy provides a broad overview of several aspects of basic sciences and clinical and therapeutic aspects of immunotherapy for ovarian cancer, as well as state-of-the-art information on molecular genetics and biology. Chapters are written by a team of expert contributors from around the world and explore topics such as antibody therapeutics for ovarian carcinoma, emerging serum biomarkers, ovarian cancer immunity, adoptive cell immunotherapy, the biology of dendritic cells, the role of growth factors, and more. Readers will also gain a better understanding of the molecular and cellular events that underlie ovarian cancer immunology. This book is an ideal reference for clinicians and medical students caring for patients with ovarian cancer, including attending surgeons and physicians, and clinical fellows and residents in the disciplines of gynecologic oncology, medical oncology, and surgical oncology.
APA, Harvard, Vancouver, ISO, and other styles
36

Meijer, Sybren L. Tumor-reactive T Cell Induction in Clinical Immunotherapy. Thela Thesis, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

Shi, Qihui, Wei Wei, and Ziming Li, eds. Single-cell Molecular Characterization for Improving Cancer Immunotherapy. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88974-479-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Armitage, James. Blood Stem Cell Transplantation. Taylor & Francis, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Immunotherapy of Renal Cell Carcinoma: Clinical and Experimental Developments. Springer, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
40

Ludewig, Burkhard, and Matthias W. Hoffmann. Adoptive Immunotherapy: Methods and Protocols. Humana Press, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
41

Adoptive immunotherapy: Methods and protocols. Totowa, NJ: Humana Press, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
42

Immunotherapy of Renal Cell Carcinoma: Clinical and Experimental Developments. Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
43

Dal Col, Jessica, Alejandro López-Soto, and Riccardo Dolcetti, eds. Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors. Frontiers Media SA, 2020. http://dx.doi.org/10.3389/978-2-88963-726-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Debruuyne, F. M. J. Immunotherapy of Renal Cell Carcinoma: Clinical and Experimental Developments. Springer, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
45

R. J. A. van Moorselaar, Pieter H. M. de Mulder, Ronald M. Bukowski, J. Edson Pontes, and Frans M. J. Debruyne. Immunotherapy of Renal Cell Carcinoma: Clinical and Experimental Developments. Springer London, Limited, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
46

Ikeda, Yasuo. Cell Therapy. Springer-Verlag, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
47

Winter, Jane N. Blood Stem Cell Transplantation. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
48

Winter, Jane N. Blood Stem Cell Transplantation. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
49

Biology of Renal Cell Carcinoma. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
50

Donnadieu, Emmanuel. Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy. Springer London, Limited, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Cell Immunotherapy' for other source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography